704 Results

People

  1. Rusch
    Rusch
  2. Travis
    Travis
  3. Rudin
    Rudin
  4. Kris
    Kris
  5. Riely
    Riely
  6. Rimner
    Rimner
  7. Jones
    Jones
  8. Ladanyi
    Ladanyi
  9. Gomez
    Gomez
  10. Yu
    Yu

Groups

  1. Department of Medicine (303)
  2. Solid Tumor Oncology Division (281)
  3. Thoracic Oncology (228)
  4. GSK Faculty (144)
  5. Department of Pathology and Laboratory Medicine (141)
  6. Surgery (134)
  7. Sloan Kettering Institute Postdocs (120)
  8. Epidemiology and Biostatistics (79)
  9. Human Oncology and Pathogenesis Program (76)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (74)
  1. "lung tumor"
Formats
  1. Journal Article (579)
  2. Review (49)
  3. Editorial (32)
  4. Guidelines (16)
  5. Conference Paper (12)
  6. Correspondence (9)
  7. Research Letter (6)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (303)
  2. Solid Tumor Oncology Division (281)
  3. Thoracic Oncology (228)
  4. GSK Faculty (144)
  5. Department of Pathology and Laboratory Medicine (141)
  6. Surgery (134)

More Groups

People
  1. Valerie Rusch (58)
  2. William Travis (53)
  3. Charles Rudin (46)
  4. Mark Kris (45)
  5. Gregory Riely (43)
  6. Andreas Rimner (36)

More People

Years
  1. 2025 (49)
  2. 2024 (115)
  3. 2023 (113)
  4. 2022 (101)
  5. 2021 (10)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Journal of Thoracic Oncology (37)
  3. Clinical Cancer Research (34)
  4. Journal of Thoracic and Cardiovascular Surgery (21)
  5. Cancer (16)
  6. Medical Physics (16)

More Publications

Publishers
  1. Elsevier Inc. (95)
  2. American Association for Cancer Research (62)
  3. American Society of Clinical Oncology (45)
  4. Nature Publishing Group (44)
  5. Springer (38)
  6. Elsevier Science, Inc. (29)

More Publishers

Results (704)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in patients with metastatic non-small cell lung cancer treated with chemotherapy
    Journal Article

    McKelvey, B. A.; Garrett-Mayer, E.; Rivera, D. R.; Alabaster, A.; Andrews, H. S.; Bond, E. G.; Brown, T. D.; Bruno, A.; Damato, L.; Espirito, J. L.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Long-term prospective outcomes of intensity modulated radiotherapy for locally advanced lung cancer a secondary analysis of a randomized clinical trial
    Journal Article

    Chun, S. G.; Hu, C.; Komaki, R. U.; Timmerman, R. D.; Schild, S. E.; Bogart, J. A.; Dobelbower, M. C.; Bosch, W.; Kavadi, V. S.; Narayan, S.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • A randomized, multi-center, open label study to compare the safety and efficacy between afatinib monotherapy and combination therapy with HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
    Journal Article

    Kwag, E.; Kim, S. D.; Shin, S. H.; Oak, C.; Park, S. J.; Choi, J. Y.; Hoon Yoon, S.; Kang, I. C.; Jeong, M. K.; Woo Lee, H.; more...
    Integrative Cancer Therapies (2024)

    Fulltext@MSK | Save
  • Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: The phase III SPINET study
    Journal Article

    Baudin, E.; Capdevila, J.; Hörsch, D.; Singh, S.; Caplin, M. E.; Wolin, E. M.; Buikhuisen, W.; Raderer, M.; Dansin, E.; Grohe, C.; more...
    Endocrine-Related Cancer (2024)

    Fulltext@MSK | Save
  • Exploring the discrepancies between clinical trials and real-world data: A small-cell lung cancer study
    Journal Article

    Marzano, L.; Darwich, A. S.; Dan, A.; Tendler, S.; Lewensohn, R.; De Petris, L.; Raghothama, J.; Meijer, S.
    CTS-Clinical and Translational Science (2024)

    Fulltext@MSK | Save
  • In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAF(V600E) lung adenocarcinoma
    Journal Article

    Nokin, M. J.; Darbo, E.; Richard, E.; San José, S.; de Hita, S.; Prouzet-Mauleon, V.; Turcq, B.; Gerardelli, L.; Crake, R.; Velasco, V.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors
    Journal Article

    Pecci, F.; Nakazawa, S.; Ricciuti, B.; Harada, G.; Lee, J. K.; Alessi, J. V.; Barrichello, A.; Vaz, V. R.; Lamberti, G.; Di Federico, A.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
    Journal Article

    He, T.; Xiao, L.; Qiao, Y.; Klingbeil, O.; Young, E.; Wu, X. S.; Mannan, R.; Mahapatra, S.; Redin, E.; Cho, H.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Utilizing a patient advocacy-led clinical network to engage diverse, community-based sites in implementation-effectiveness research
    Journal Article

    Ciupek, A.; Chichester, L. A.; Acharya, R.; Schofield, E.; Criswell, A.; Shelley, D.; King, J. C.; Ostroff, J. S.
    BMC Health Services Research (2024)

    Fulltext@MSK | Save
  • Induction therapy for non–small cell lung cancer
    Editorial

    Cooper, A.; Chaft, J. E.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save